Highway Holdings Limited, including its various subsidiaries, is primarily involved in the creation and distribution of a wide array of components, subassemblies, and complete products. These offerings encompass metal, plastic, electrical, and electronic categories, catering mainly to original equipment manufacturers (OEMs) and contract-based production companies. The firm's activities are structured into two distinct divisions: Metal Stamping and Mechanical OEM, and Electric OEM. Beyond its core manufacturing, Highway Holdings also deals in plastic injection molded items and fabricates specialized automation machinery. Their diverse product range is integrated into numerous consumer and industrial goods, such as photocopiers, laser printers, print cartridges, various electrical connectors and circuits, vacuum cleaners, LED power supplies, stepping motors, dishwasher pumps, and other washing machine parts. Moreover, the company extends its expertise by assisting clients with the conceptualization and development of tooling crucial for both metal and plastic fabrication processes. Their extensive suite of manufacturing and engineering services includes precision metal stamping, screen printing, plastic injection molding, pad printing, and the electronic assembly of printed circuit boards. Founded in 1990, Highway Holdings Limited maintains its corporate headquarters in Sheung Shui, Hong Kong, with operations spanning Hong Kong, China, Europe, North America, and various other Asian territories.
Highway Holdings Receives Additional 180-Day Nasdaq Extension to Regain Minimum Bid Price Compliance
Highway Holdings received a second 180-day extension from Nasdaq to regain compliance with the minimum bid price requirement, giving the company until March 15, 2027, with shares continuing to trade uninterrupted under the ticker HIHO.
To regain compliance, the closing bid price must be at least US$1.00 per share for at least ten consecutive business days by the new deadline.
The company said it may effect a reverse stock split if necessary to cure the deficiency, and a second extension confirms the stock traded below $1.00 throughout the initial 180-day period, keeping delisting risk alive.